Company: SXTPW
Filing Date: 2025-06-06
Form Type: DRS
Source: 0001213900-25-052232
Chunk: 46

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-06-06
Form: DRS
Chunk 46
---
 the common stock; limited news and analyst coverage for our Company, in part due to the “penny stock”
rules; decreased ability to issue additional securities or obtain additional financing in the future; and potential breaches under or
terminations of our agreements with current or prospective large stockholders, strategic investors and banks. The perception among investors
that we are at heightened risk of delisting could also negatively affect the market price of our securities and trading volume of our
common stock.

A possible “short squeeze” due to a sudden increase in demand of our common stock that largely exceeds supply may lead to price volatility in our common stock.

Investors may purchase our common stock to hedge
existing exposure in our common stock or to speculate on the price of our common stock. Speculation on the price of our common stock may
involve long and short exposures. To the extent aggregate short exposure exceeds the number of shares of our common stock available for
purchase in the open market, investors with short exposure may have to pay a premium to repurchase our common stock for delivery to lenders
of our common stock. Those repurchases may in turn dramatically increase the price of our common stock until investors with short exposure
are able to purchase additional shares of common stock to cover their short position. This is often referred to as a “short squeeze.”
A short squeeze could lead to volatile price movements in our common stock that are not directly correlated to the performance or prospects
of our Company and once investors purchase the shares of common stock necessary to cover their short position, the price of our common
stock may decline.

You should consult your own independent tax advisor regarding any tax matters arising with respect to the securities offered in connection with this offering.

Participation in this offering could result in
various tax-related consequences for investors. All prospective purchasers of the resold securities are advised to consult their own independent
tax advisors regarding the U.S. federal, state, local and non-U.S. tax consequences relevant to the purchase, ownership and disposition
of the resold securities in their particular situations.

We have not paid dividends in the past and do not expect to pay dividends in the future, and any return on investment may be limited to the value of our stock.

We have never declared or paid cash dividends
on our common stock since inception as this is not how an LLC returns capital to its members and do not anticipate paying any cash dividends
on our common stock as a C-Corporation in the foreseeable future. Instead, we currently intend to retain any future earnings